The blood-brain barrier (BBB) is a complex cellular system that separates the central nervous system (CNS) from the bloodstream whose purpose is to maintain the homeostasis of the CNS and protection of the brain from xenobiotics. As a result, the efficacy of CNS-targeted drugs, is limited by insufficient delivering into brain, while for systemically targeted drugs, low BBB penetration is needed for decreasing CNS adverse effects. Accordingly, prediction of drug permeation across BBB is an important issue in drug discovery investigations.
According to these studies, one of the more accurate models was proposed by Abraham et al., which correlated log BB to the Abraham solvation parameters of drugs including excess molar refraction, solute polarity/polarizability, solute hydrogen bond acidity and basicity, and McGowan which characteristic molar volume. 4, 5) Feher et al. 6) proposed quantitative structure-property relationship (QSPR) models based on calculated octanol-water partition coefficient, the number of hydrogen-bond acceptors in aqueous medium, and the polar surface area. Subramanian and Kitchen 7) employed a linear regression and a multivariate genetic partial least squares (G/PLS) approach to predict log BB. They employed seven descriptors available in the Cerius package. Another QSPR model using multivariate partial least square (PLS) using 25 calculated descriptors was proposed by Luco. 8) Recently, Fu et al. 9) proposed a QSPR model using molecular weight and number of polar atoms and another QSPR model using molar volume and partial surface area. 10) Wichmann et al. 11) applied a set of 5 COSMO-RS s-moments obtained from quantum chemical calculations as descriptors. Artificial neural networks (ANNs) were also applied for predicting log BB 2) by Chen et al. 12) Futhure details of reviewed in silico models are summarized in Table 1 . Classification is a common method in chemical disciplines that was used for BBB modeling along with chemometrics methods.
2) Molecular charge and ionization state are critical parameters in determination of pharmacokinetic properties such as log BB. Some drugs are in their ionized form in pH 7.4, while others are in neutral forms. Classification according to ionization provides a useful method in pharmacokinetic data modeling. As an example Ghafourian et al. 13) developed a QSPR model for the prediction of apparent volume of distribution in which drugs were classified in two classes of acidic and basic groups.
Although attempts were made to predict BBB transport with several physicochemical parameters, in particular with the octanol-water partition coefficient (log P), 2) however, in some cases poor correlation was found between log BB and log P. 8) A possible reason for such a poor correlation might be related to the ionization state of drugs that affect log P and consequently log BB, e.g. log P of aspirin is 1.22 where log D 7.4 is Ϫ2.47.
14) log D 7.4 is the overall ratio of drug, in ionized and non-ionized forms, between octanol and buffer in pHϭ7.4.
15)
The aims of this study are classification of compounds according to their ionization states in blood pH and proposing two simple QSPR models using multiple linear regression (MLR) analysis. Descriptors are calculated by PharmaAlgorithms software, selected by stepwise regression; the validity and accuracy of the proposed models are investigated and compared with previous models.
COMPUTATIONAL METHODS
Log BB values of 122 drugs and chemical compounds were collected from the literature. 4, 12, 16, 17) The dataset was classified according to their ionization state in blood pH using the logarithm of the distribution coefficient in octanol/ water (log D) at pH 1.7 (log D 1.7 ) and pH 7.4 (log D 7.4 ). Thus a compound was allocated to the ionized group at pHϭ7.4 if log D 1.7 Ͻlog D 7.4 and was classified as the un-ionized group at pH 7.4 if log D 1.7 Նlog D 7.4 . Each group was divided to train and test sets. To do this, log BB values were sorted based on the ascending order, and from every five compounds one was assigned as test set (12 compounds in each group) and the remainder considered as train set (49 compounds in each group). Calculated Abraham solvation parameters, molecular weight (MW), topological polar surface area (TPSA), log D 7.4 , number of hydrogen bond donor (NHBD), number of hydrogen bond acceptor (NHBA), and calculated log P (c log P) value using Pharma-Algorithms software were used as descriptors. A stepwise regression analysis was employed to select the most significant predictors. The selected descriptors for each dataset (ionized and un-ionized) were correlated with log BB values using MLR method. To validate the proposed models and to assess their prediction capability, the leave-one out (LOO) method was used in which one compound is left out from the training set and the trained model was used to predict the removed data point. The LOO results (q 2 values) are inadequate to assess the validity of a model, so the external validation method was used to establish a reliable QSPR model considering the following criteria taken from the literature [18] [19] [20] : Criterion 1: R 2 Ͼ0.6 and q 2 Ͼ0.5 where R 2 is the correlation coefficient between the predicted and experimental values of compounds and q 2 is defined as following: (7) y i and y i Ј are experimental and predicted values, respectively, n is number of compounds in the validation set, and y ස Train set indicates the means of the training and validation sets. In addition to the above validation process an external test set containing 25 drugs, which was proposed in the literature to compare the prediction power of the proposed model with previous models, was employed.
The accuracy of the predicted log BB values is calculated by average absolute error (AAE) and root mean square error (RMSE) criteria, which are defined as:
RESULTS AND DISCUSSION Experimental and predicted log BB values for the training and test sets along with the numerical values of the selected descriptors are listed in Table 2 . The developed QSPR model for un-ionizable compounds in blood pH is: (10) and for ionizable compounds is: (11) where N is the number of compounds, R 2 the regression coefficient, q 2 LOO the cross validation coefficient, s the standard deviation, and F the Fisher F-statistic.
For un-ionizable compounds in blood, log D 7.4 and MW are the significant parameters for determining log BB. log P has been reported in the literature as a critical parameter in log BB prediction. 1, 3) However, it provides no information about the ionization state of drugs, so log D 7.4 (log P in pH 7.4) can be replaced as a more efficient parameter in log BB modeling. Higher log D 7.4 values are favorable for log BB whereas lower MW increases log BB and represents a combined effect of molecular size and lipophilicity on log BB. 9) For ionizable compounds that are not ionized in blood pH, 
. . NHBA is the most effective parameter in which drugs with more hydrogen bond acceptor sites have lower permeation to brain. The impact of hydrogen bonding on log BB has been recognized and some models for prediction of log BB have been reported in the literature.
1) Table 3 shows the correlations between selected parameters and calculated log BB values and their intercorrelation. The selected descriptors were not significantly correlated with each other. For un-ionizable compounds, both log D 7. 4 and MW are important, whereas for ionizable compounds 
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a) The data were sorted based on f log BB values and from every five compounds one was assigned as test set and the remained were determined as train set. b) A compound was allocated to the un-ionized group (group 1) if log D 1.7 Նlog D 7.4 and to the ionized group (group 2) if the log D 1.7 Ͻlog D 7.4 . c) Molecular weight. d) Number of hydrogen bond acceptor. e) AE is absolute error and is calculated using AEϭ|log BB experimental Ϫlog BB calculated |. f ) AAE is absolute average error and is computed by: AAEϭ(Í N AE)/N. hydrogen bond is very important and log D 7.4 has partial effect.
The overall AAE value for train sets was 0.337Ϯ0.291 (0.264Ϯ0.237 and 0.410Ϯ0.322 for ionizable and un-ionizable compounds, respectively). The corresponding value for test sets was 0.298Ϯ0.252 (0.254Ϯ0.160 and 0.342Ϯ0.321 for ionizable and un-ionizable compounds, respectively). Figure 1 shows the relative frequencies of absolute error for each compound sorted into three subgroups, such as Յ0.3, 0.3-0.8, and Ͼ0.8. The acceptable AE for log BB prediction is 0.3 log unit.
3) Figure 1 shows that Ͼ60% of data were predicted by AE values Ͻ0.3 log unit. Overall RMSE values of train set was 0.444 (0.353 and 0.519 for un-ionizable and ionizable compounds, respectively) and for test set 0.387 (0.296 and 0.460 for un-ionizable and ionizable compounds, Table 1 , i: predicted using Eqs. 10 and 11, this study. a to h: predicted using previous methods, i: predicted using Eqs. 10 and 11, this study.
respectively) which shows a similar accuracy pattern with AAE. Comparison of the Proposed Models with Previous Models A dataset of 25 data points proposed in the literature as external dataset was employed to assess the accuracies of the proposed models and to compare them with previous models. 8, 9) The experimental and predicted values of log BB are listed in Table 5 . Figure 2 shows AAE and RMSE of the models. As can be seen, the models produced the same accuracy pattern considering AAE and RMSE criteria. The results suggest that the proposed models can predict log BB accurately and a simple classification could improve prediction of log BB.
Model Validation

CONCLUSION
MLR was used to propose simple and accurate log BB prediction model. Classification (according to ionization state) can be a useful method to improve log BB prediction. log D 7.4 and MW or NHBA for un-ionizable and ionizable compounds, respectively, are critical parameters for log BB prediction. Proposed models are very simple and interpretative, and can be easily used the rapid prediction of log BB in drug discovery investigations.
